Corporate Buyout

Citi Pharma Secures Competition Commission Approval To Acquire Pakheim International Pharma

The 100% equity buyout aims to scale Pakheim's revenue to Rs5 billion within five years while driving vertical integration in active pharmaceutical ingredients.

By The Scoop desk / 3 min read